APO Research
Talk to an analyst

APO RESEARCH · REPORT

Albumin (Human)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Albumin (Human) Market Analysis and Forecast 2026-2032

20 December 2025190 pages

Choose your research edition.

Industry ResearchAlbumin (Human) Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Albumin (Human) Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Albumin (Human) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Albumin (Human) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Albumin (Human) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Albumin (Human) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Albumin (Human) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Albumin (Human) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Albumin (Human) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Albumin (Human) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Albumin (Human) include CSL Behring, Grifols, Octapharma, Baxter, Hualan Bio, Shanghai Laishi, Taibang Bio and Zhongsheng Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Albumin (Human), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Albumin (Human), also provides the sales of main regions and countries. Of the upcoming market potential for Albumin (Human), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Albumin (Human) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Albumin (Human) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Albumin (Human) sales, projected growth trends, production technology, application and end-user industry.

Albumin (Human) Segment by Company

CSL Behring

Grifols

Octapharma

Baxter

Hualan Bio

Shanghai Laishi

Taibang Bio

Zhongsheng Group

Albumin (Human) Segment by Type

Injection

Freeze-dried Injection

Albumin (Human) Segment by Application

Liver Diseases

Kidney Diseases

Neoplasm

Other Diseases

Albumin (Human) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albumin (Human) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Albumin (Human) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albumin (Human).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Albumin (Human) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Albumin (Human) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Albumin (Human) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Albumin (Human) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Manufacturers Table 3. Freeze-dried Injection Major Manufacturers Table 4. Global Albumin (Human) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Liver Diseases Major Manufacturers Table 6. Kidney Diseases Major Manufacturers Table 7. Neoplasm Major Manufacturers Table 8. Other Diseases Major Manufacturers Table 9. Albumin (Human) Industry Trends Table 10. Albumin (Human) Industry Drivers Table 11. Albumin (Human) Industry Opportunities and Challenges Table 12. Albumin (Human) Industry Restraints Table 13. Global Albumin (Human) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Albumin (Human) Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Albumin (Human) Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Albumin (Human) Revenue Market Share by Region (2021-2026) Table 17. Global Albumin (Human) Revenue Market Share by Region (2027-2032) Table 18. Global Albumin (Human) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Albumin (Human) Sales by Region (2021-2026) & (K Units) Table 20. Global Albumin (Human) Sales by Region (2027-2032) & (K Units) Table 21. Global Albumin (Human) Sales Market Share by Region (2021-2026) Table 22. Global Albumin (Human) Sales Market Share by Region (2027-2032) Table 23. Global Albumin (Human) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Albumin (Human) Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Albumin (Human) Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Albumin (Human) Sales Market Share by Manufacturers (2021-2026) Table 27. Global Albumin (Human) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Albumin (Human) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Albumin (Human) Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Albumin (Human) Manufacturers, Product Type & Application Table 31. Global Albumin (Human) Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Albumin (Human) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Albumin (Human) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Albumin (Human) Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Albumin (Human) Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Albumin (Human) Revenue Market Share by Type (2021-2026) Table 38. Global Albumin (Human) Revenue Market Share by Type (2027-2032) Table 39. Global Albumin (Human) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Albumin (Human) Sales by Type (2021-2026) & (K Units) Table 41. Global Albumin (Human) Sales by Type (2027-2032) & (K Units) Table 42. Global Albumin (Human) Sales Market Share by Type (2021-2026) Table 43. Global Albumin (Human) Sales Market Share by Type (2027-2032) Table 44. Global Albumin (Human) Price by Type (2021-2026) & (US$/Unit) Table 45. Global Albumin (Human) Price by Type (2027-2032) & (US$/Unit) Table 46. Global Albumin (Human) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Albumin (Human) Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Albumin (Human) Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Albumin (Human) Revenue Market Share by Application (2021-2026) Table 50. Global Albumin (Human) Revenue Market Share by Application (2027-2032) Table 51. Global Albumin (Human) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Albumin (Human) Sales by Application (2021-2026) & (K Units) Table 53. Global Albumin (Human) Sales by Application (2027-2032) & (K Units) Table 54. Global Albumin (Human) Sales Market Share by Application (2021-2026) Table 55. Global Albumin (Human) Sales Market Share by Application (2027-2032) Table 56. Global Albumin (Human) Price by Application (2021-2026) & (US$/Unit) Table 57. Global Albumin (Human) Price by Application (2027-2032) & (US$/Unit) Table 58. CSL Behring Company Information Table 59. CSL Behring Business Overview Table 60. CSL Behring Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. CSL Behring Albumin (Human) Product Portfolio Table 62. CSL Behring Recent Development Table 63. Grifols Company Information Table 64. Grifols Business Overview Table 65. Grifols Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Grifols Albumin (Human) Product Portfolio Table 67. Grifols Recent Development Table 68. Octapharma Company Information Table 69. Octapharma Business Overview Table 70. Octapharma Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Octapharma Albumin (Human) Product Portfolio Table 72. Octapharma Recent Development Table 73. Baxter Company Information Table 74. Baxter Business Overview Table 75. Baxter Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Baxter Albumin (Human) Product Portfolio Table 77. Baxter Recent Development Table 78. Hualan Bio Company Information Table 79. Hualan Bio Business Overview Table 80. Hualan Bio Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Hualan Bio Albumin (Human) Product Portfolio Table 82. Hualan Bio Recent Development Table 83. Shanghai Laishi Company Information Table 84. Shanghai Laishi Business Overview Table 85. Shanghai Laishi Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Shanghai Laishi Albumin (Human) Product Portfolio Table 87. Shanghai Laishi Recent Development Table 88. Taibang Bio Company Information Table 89. Taibang Bio Business Overview Table 90. Taibang Bio Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Taibang Bio Albumin (Human) Product Portfolio Table 92. Taibang Bio Recent Development Table 93. Zhongsheng Group Company Information Table 94. Zhongsheng Group Business Overview Table 95. Zhongsheng Group Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Zhongsheng Group Albumin (Human) Product Portfolio Table 97. Zhongsheng Group Recent Development Table 98. North America Albumin (Human) Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Albumin (Human) Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Albumin (Human) Sales by Type (2021-2026) & (K Units) Table 101. North America Albumin (Human) Sales by Type (2027-2032) & (K Units) Table 102. North America Albumin (Human) Sales Price by Type (2021-2026) & (US$/Unit) Table 103. North America Albumin (Human) Sales Price by Type (2027-2032) & (US$/Unit) Table 104. North America Albumin (Human) Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Albumin (Human) Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Albumin (Human) Sales by Application (2021-2026) & (K Units) Table 107. North America Albumin (Human) Sales by Application (2027-2032) & (K Units) Table 108. North America Albumin (Human) Sales Price by Application (2021-2026) & (US$/Unit) Table 109. North America Albumin (Human) Sales Price by Application (2027-2032) & (US$/Unit) Table 110. North America Albumin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Albumin (Human) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Albumin (Human) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Albumin (Human) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 114. North America Albumin (Human) Sales by Country (2021-2026) & (K Units) Table 115. North America Albumin (Human) Sales by Country (2027-2032) & (K Units) Table 116. North America Albumin (Human) Sales Price by Country (2021-2026) & (US$/Unit) Table 117. North America Albumin (Human) Sales Price by Country (2027-2032) & (US$/Unit) Table 118. United States Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 119. Canada Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 120. Europe Albumin (Human) Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Albumin (Human) Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Albumin (Human) Sales by Type (2021-2026) & (K Units) Table 123. Europe Albumin (Human) Sales by Type (2027-2032) & (K Units) Table 124. Europe Albumin (Human) Sales Price by Type (2021-2026) & (US$/Unit) Table 125. Europe Albumin (Human) Sales Price by Type (2027-2032) & (US$/Unit) Table 126. Europe Albumin (Human) Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Albumin (Human) Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Albumin (Human) Sales by Application (2021-2026) & (K Units) Table 129. Europe Albumin (Human) Sales by Application (2027-2032) & (K Units) Table 130. Europe Albumin (Human) Sales Price by Application (2021-2026) & (US$/Unit) Table 131. Europe Albumin (Human) Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Europe Albumin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Albumin (Human) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe Albumin (Human) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe Albumin (Human) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 136. Europe Albumin (Human) Sales by Country (2021-2026) & (K Units) Table 137. Europe Albumin (Human) Sales by Country (2027-2032) & (K Units) Table 138. Europe Albumin (Human) Sales Price by Country (2021-2026) & (US$/Unit) Table 139. Europe Albumin (Human) Sales Price by Country (2027-2032) & (US$/Unit) Table 140. Germany Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 141. France Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 142. U.K. Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 143. Italy Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 144. Netherlands Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 145. China Albumin (Human) Revenue by Type (2021-2026) & (US$ Million) Table 146. China Albumin (Human) Revenue by Type (2027-2032) & (US$ Million) Table 147. China Albumin (Human) Sales by Type (2021-2026) & (K Units) Table 148. China Albumin (Human) Sales by Type (2027-2032) & (K Units) Table 149. China Albumin (Human) Sales Price by Type (2021-2026) & (US$/Unit) Table 150. China Albumin (Human) Sales Price by Type (2027-2032) & (US$/Unit) Table 151. China Albumin (Human) Revenue by Application (2021-2026) & (US$ Million) Table 152. China Albumin (Human) Revenue by Application (2027-2032) & (US$ Million) Table 153. China Albumin (Human) Sales by Application (2021-2026) & (K Units) Table 154. China Albumin (Human) Sales by Application (2027-2032) & (K Units) Table 155. China Albumin (Human) Sales Price by Application (2021-2026) & (US$/Unit) Table 156. China Albumin (Human) Sales Price by Application (2027-2032) & (US$/Unit) Table 157. Asia Albumin (Human) Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Albumin (Human) Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Albumin (Human) Sales by Type (2021-2026) & (K Units) Table 160. Asia Albumin (Human) Sales by Type (2027-2032) & (K Units) Table 161. Asia Albumin (Human) Sales Price by Type (2021-2026) & (US$/Unit) Table 162. Asia Albumin (Human) Sales Price by Type (2027-2032) & (US$/Unit) Table 163. Asia Albumin (Human) Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Albumin (Human) Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Albumin (Human) Sales by Application (2021-2026) & (K Units) Table 166. Asia Albumin (Human) Sales by Application (2027-2032) & (K Units) Table 167. Asia Albumin (Human) Sales Price by Application (2021-2026) & (US$/Unit) Table 168. Asia Albumin (Human) Sales Price by Application (2027-2032) & (US$/Unit) Table 169. Asia Albumin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Albumin (Human) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Albumin (Human) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Albumin (Human) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 173. Asia Albumin (Human) Sales by Country (2021-2026) & (K Units) Table 174. Asia Albumin (Human) Sales by Country (2027-2032) & (K Units) Table 175. Asia Albumin (Human) Sales Price by Country (2021-2026) & (US$/Unit) Table 176. Asia Albumin (Human) Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Japan Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 178. South Korea Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 179. India Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 180. Australia Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 181. China Taiwan Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Albumin (Human) Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Albumin (Human) Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Albumin (Human) Sales by Type (2021-2026) & (K Units) Table 186. SAMEA Albumin (Human) Sales by Type (2027-2032) & (K Units) Table 187. SAMEA Albumin (Human) Sales Price by Type (2021-2026) & (US$/Unit) Table 188. SAMEA Albumin (Human) Sales Price by Type (2027-2032) & (US$/Unit) Table 189. SAMEA Albumin (Human) Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Albumin (Human) Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Albumin (Human) Sales by Application (2021-2026) & (K Units) Table 192. SAMEA Albumin (Human) Sales by Application (2027-2032) & (K Units) Table 193. SAMEA Albumin (Human) Sales Price by Application (2021-2026) & (US$/Unit) Table 194. SAMEA Albumin (Human) Sales Price by Application (2027-2032) & (US$/Unit) Table 195. SAMEA Albumin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Albumin (Human) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Albumin (Human) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Albumin (Human) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 199. SAMEA Albumin (Human) Sales by Country (2021-2026) & (K Units) Table 200. SAMEA Albumin (Human) Sales by Country (2027-2032) & (K Units) Table 201. SAMEA Albumin (Human) Sales Price by Country (2021-2026) & (US$/Unit) Table 202. SAMEA Albumin (Human) Sales Price by Country (2027-2032) & (US$/Unit) Table 203. Brazil Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 204. Argentina Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 205. Chile Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 206. Colombia Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 207. Peru Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 209. Israel Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 210. UAE Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 211. Turkey Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 212. Iran Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 213. Egypt Albumin (Human) Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Albumin (Human) Distributors List Table 217. Albumin (Human) Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Albumin (Human) Image Figure 2. Global Albumin (Human) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Albumin (Human) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. Freeze-dried Injection Image Figure 6. Global Albumin (Human) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Albumin (Human) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Liver Diseases Image Figure 9. Kidney Diseases Image Figure 10. Neoplasm Image Figure 11. Other Diseases Image Figure 12. Global Albumin (Human) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Albumin (Human) Revenue (2021-2032) & (US$ Million) Figure 14. Global Albumin (Human) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Albumin (Human) Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Albumin (Human) Revenue Market Share by Region (2021-2032) Figure 17. Global Albumin (Human) Sales (2021-2032) & (K Units) Figure 18. Global Albumin (Human) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Albumin (Human) Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Albumin (Human) Sales YoY (2021-2032) & (K Units) Figure 21. Europe Albumin (Human) Sales YoY (2021-2032) & (K Units) Figure 22. China Albumin (Human) Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Albumin (Human) Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Albumin (Human) Sales YoY (2021-2032) & (K Units) Figure 25. Global Albumin (Human) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Albumin (Human) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Albumin (Human) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Albumin (Human) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Albumin (Human) Revenue Market Share by Type (2021-2032) Figure 31. Global Albumin (Human) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Albumin (Human) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Albumin (Human) Sales Market Share by Type (2021-2032) Figure 34. Global Albumin (Human) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Albumin (Human) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Albumin (Human) Revenue Market Share by Application (2021-2032) Figure 37. Global Albumin (Human) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Albumin (Human) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Albumin (Human) Sales Market Share by Application (2021-2032) Figure 40. North America Albumin (Human) Revenue Share by Type (2021-2032) Figure 41. North America Albumin (Human) Sales Share by Type (2021-2032) Figure 42. North America Albumin (Human) Revenue Share by Application (2021-2032) Figure 43. North America Albumin (Human) Sales Share by Application (2021-2032) Figure 44. North America Albumin (Human) Revenue Share by Country (2021-2032) Figure 45. North America Albumin (Human) Sales Share by Country (2021-2032) Figure 46. Europe Albumin (Human) Revenue Share by Type (2021-2032) Figure 47. Europe Albumin (Human) Sales Share by Type (2021-2032) Figure 48. Europe Albumin (Human) Revenue Share by Application (2021-2032) Figure 49. Europe Albumin (Human) Sales Share by Application (2021-2032) Figure 50. Europe Albumin (Human) Revenue Share by Country (2021-2032) Figure 51. Europe Albumin (Human) Sales Share by Country (2021-2032) Figure 52. China Albumin (Human) Revenue Share by Type (2021-2032) Figure 53. China Albumin (Human) Sales Share by Type (2021-2032) Figure 54. China Albumin (Human) Revenue Share by Application (2021-2032) Figure 55. China Albumin (Human) Sales Share by Application (2021-2032) Figure 56. Asia Albumin (Human) Revenue Share by Type (2021-2032) Figure 57. Asia Albumin (Human) Sales Share by Type (2021-2032) Figure 58. Asia Albumin (Human) Revenue Share by Application (2021-2032) Figure 59. Asia Albumin (Human) Sales Share by Application (2021-2032) Figure 60. Asia Albumin (Human) Revenue Share by Country (2021-2032) Figure 61. Asia Albumin (Human) Sales Share by Country (2021-2032) Figure 62. SAMEA Albumin (Human) Revenue Share by Type (2021-2032) Figure 63. SAMEA Albumin (Human) Sales Share by Type (2021-2032) Figure 64. SAMEA Albumin (Human) Revenue Share by Application (2021-2032) Figure 65. SAMEA Albumin (Human) Sales Share by Application (2021-2032) Figure 66. SAMEA Albumin (Human) Revenue Share by Country (2021-2032) Figure 67. SAMEA Albumin (Human) Sales Share by Country (2021-2032) Figure 68. Albumin (Human) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Albumin (Human) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Freeze-dried Injection
Applications
  • Liver Diseases
  • Kidney Diseases
  • Neoplasm
  • Other Diseases
Companies covered
  • CSL Behring
  • Grifols
  • Octapharma
  • Baxter
  • Hualan Bio
  • Shanghai Laishi
  • Taibang Bio
  • Zhongsheng Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Albumin (Human) Market by Type
  3. 1.2.1 Global Albumin (Human) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Freeze-dried Injection
  6. 1.3 Albumin (Human) Market by Application
  7. 1.3.1 Global Albumin (Human) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Liver Diseases
  9. 1.3.3 Kidney Diseases
  10. 1.3.4 Neoplasm
  11. 1.3.5 Other Diseases
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Albumin (Human) Market Dynamics
  1. 2.1 Albumin (Human) Industry Trends
  2. 2.2 Albumin (Human) Industry Drivers
  3. 2.3 Albumin (Human) Industry Opportunities and Challenges
  4. 2.4 Albumin (Human) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Albumin (Human) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Albumin (Human) Revenue by Region
  3. 3.2.1 Global Albumin (Human) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Albumin (Human) Revenue by Region (2021-2026)
  5. 3.2.3 Global Albumin (Human) Revenue by Region (2027-2032)
  6. 3.2.4 Global Albumin (Human) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Albumin (Human) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Albumin (Human) Sales by Region
  9. 3.4.1 Global Albumin (Human) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Albumin (Human) Sales by Region (2021-2026)
  11. 3.4.3 Global Albumin (Human) Sales by Region (2027-2032)
  12. 3.4.4 Global Albumin (Human) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Albumin (Human) Revenue by Manufacturers
  2. 4.1.1 Global Albumin (Human) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Albumin (Human) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Albumin (Human) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Albumin (Human) Sales by Manufacturers
  6. 4.2.1 Global Albumin (Human) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Albumin (Human) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Albumin (Human) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Albumin (Human) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Albumin (Human) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Albumin (Human) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Albumin (Human) Manufacturers, Product Type & Application
  13. 4.7 Global Albumin (Human) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Albumin (Human) Market CR5 and HHI
  16. 4.8.2 2025 Albumin (Human) Tier 1, Tier 2, and Tier 3
5 Albumin (Human) Market by Type
  1. 5.1 Global Albumin (Human) Revenue by Type
  2. 5.1.1 Global Albumin (Human) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Albumin (Human) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Albumin (Human) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Albumin (Human) Sales by Type
  6. 5.2.1 Global Albumin (Human) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Albumin (Human) Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Albumin (Human) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Albumin (Human) Price by Type
6 Albumin (Human) Market by Application
  1. 6.1 Global Albumin (Human) Revenue by Application
  2. 6.1.1 Global Albumin (Human) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Albumin (Human) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Albumin (Human) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Albumin (Human) Sales by Application
  6. 6.2.1 Global Albumin (Human) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Albumin (Human) Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Albumin (Human) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Albumin (Human) Price by Application
7 Company Profiles
  1. 7.1 CSL Behring
  2. 7.1.1 CSL Behring Company Information
  3. 7.1.2 CSL Behring Business Overview
  4. 7.1.3 CSL Behring Albumin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CSL Behring Albumin (Human) Product Portfolio
  6. 7.1.5 CSL Behring Recent Developments
  7. 7.2 Grifols
  8. 7.2.1 Grifols Company Information
  9. 7.2.2 Grifols Business Overview
  10. 7.2.3 Grifols Albumin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Grifols Albumin (Human) Product Portfolio
  12. 7.2.5 Grifols Recent Developments
  13. 7.3 Octapharma
  14. 7.3.1 Octapharma Company Information
  15. 7.3.2 Octapharma Business Overview
  16. 7.3.3 Octapharma Albumin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Octapharma Albumin (Human) Product Portfolio
  18. 7.3.5 Octapharma Recent Developments
  19. 7.4 Baxter
  20. 7.4.1 Baxter Company Information
  21. 7.4.2 Baxter Business Overview
  22. 7.4.3 Baxter Albumin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Baxter Albumin (Human) Product Portfolio
  24. 7.4.5 Baxter Recent Developments
  25. 7.5 Hualan Bio
  26. 7.5.1 Hualan Bio Company Information
  27. 7.5.2 Hualan Bio Business Overview
  28. 7.5.3 Hualan Bio Albumin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hualan Bio Albumin (Human) Product Portfolio
  30. 7.5.5 Hualan Bio Recent Developments
  31. 7.6 Shanghai Laishi
  32. 7.6.1 Shanghai Laishi Company Information
  33. 7.6.2 Shanghai Laishi Business Overview
  34. 7.6.3 Shanghai Laishi Albumin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Shanghai Laishi Albumin (Human) Product Portfolio
  36. 7.6.5 Shanghai Laishi Recent Developments
  37. 7.7 Taibang Bio
  38. 7.7.1 Taibang Bio Company Information
  39. 7.7.2 Taibang Bio Business Overview
  40. 7.7.3 Taibang Bio Albumin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Taibang Bio Albumin (Human) Product Portfolio
  42. 7.7.5 Taibang Bio Recent Developments
  43. 7.8 Zhongsheng Group
  44. 7.8.1 Zhongsheng Group Company Information
  45. 7.8.2 Zhongsheng Group Business Overview
  46. 7.8.3 Zhongsheng Group Albumin (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Zhongsheng Group Albumin (Human) Product Portfolio
  48. 7.8.5 Zhongsheng Group Recent Developments
8 North America
  1. 8.1 North America Albumin (Human) Market Size by Type
  2. 8.1.1 North America Albumin (Human) Revenue by Type (2021-2032)
  3. 8.1.2 North America Albumin (Human) Sales by Type (2021-2032)
  4. 8.1.3 North America Albumin (Human) Price by Type (2021-2032)
  5. 8.2 North America Albumin (Human) Market Size by Application
  6. 8.2.1 North America Albumin (Human) Revenue by Application (2021-2032)
  7. 8.2.2 North America Albumin (Human) Sales by Application (2021-2032)
  8. 8.2.3 North America Albumin (Human) Price by Application (2021-2032)
  9. 8.3 North America Albumin (Human) Market Size by Country
  10. 8.3.1 North America Albumin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Albumin (Human) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Albumin (Human) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Albumin (Human) Market Size by Type
  2. 9.1.1 Europe Albumin (Human) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Albumin (Human) Sales by Type (2021-2032)
  4. 9.1.3 Europe Albumin (Human) Price by Type (2021-2032)
  5. 9.2 Europe Albumin (Human) Market Size by Application
  6. 9.2.1 Europe Albumin (Human) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Albumin (Human) Sales by Application (2021-2032)
  8. 9.2.3 Europe Albumin (Human) Price by Application (2021-2032)
  9. 9.3 Europe Albumin (Human) Market Size by Country
  10. 9.3.1 Europe Albumin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Albumin (Human) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Albumin (Human) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Albumin (Human) Market Size by Type
  2. 10.1.1 China Albumin (Human) Revenue by Type (2021-2032)
  3. 10.1.2 China Albumin (Human) Sales by Type (2021-2032)
  4. 10.1.3 China Albumin (Human) Price by Type (2021-2032)
  5. 10.2 China Albumin (Human) Market Size by Application
  6. 10.2.1 China Albumin (Human) Revenue by Application (2021-2032)
  7. 10.2.2 China Albumin (Human) Sales by Application (2021-2032)
  8. 10.2.3 China Albumin (Human) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Albumin (Human) Market Size by Type
  2. 11.1.1 Asia Albumin (Human) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Albumin (Human) Sales by Type (2021-2032)
  4. 11.1.3 Asia Albumin (Human) Price by Type (2021-2032)
  5. 11.2 Asia Albumin (Human) Market Size by Application
  6. 11.2.1 Asia Albumin (Human) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Albumin (Human) Sales by Application (2021-2032)
  8. 11.2.3 Asia Albumin (Human) Price by Application (2021-2032)
  9. 11.3 Asia Albumin (Human) Market Size by Country
  10. 11.3.1 Asia Albumin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Albumin (Human) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Albumin (Human) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Albumin (Human) Market Size by Type
  2. 12.1.1 SAMEA Albumin (Human) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Albumin (Human) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Albumin (Human) Price by Type (2021-2032)
  5. 12.2 SAMEA Albumin (Human) Market Size by Application
  6. 12.2.1 SAMEA Albumin (Human) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Albumin (Human) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Albumin (Human) Price by Application (2021-2032)
  9. 12.3 SAMEA Albumin (Human) Market Size by Country
  10. 12.3.1 SAMEA Albumin (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Albumin (Human) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Albumin (Human) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Albumin (Human) Value Chain Analysis
  2. 13.1.1 Albumin (Human) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Albumin (Human) Production Mode & Process
  6. 13.2 Albumin (Human) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Albumin (Human) Distributors
  9. 13.2.3 Albumin (Human) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst